Prospective cohort analyzing risk factors for chronic kidney disease progression in children

Vera M S Belangero1, Liliane C Prates1, Andreia Watanabe2

  • 1Universidade Estadual de Campinas (UNICAMP), Nefrologia Pediátrica, Campinas, SP, Brazil.

Jornal De Pediatria
|October 7, 2017
PubMed

Insights

This study identified key risk factors for chronic kidney disease (CKD) progression in Brazilian children, including advanced stage, proteinuria, age, blood pressure, and anemia. Anemia may be more detrimental in children without proteinuria, warranting further investigation.

Area of Science:

  • Pediatric Nephrology
  • Chronic Kidney Disease Epidemiology
  • Risk Factor Analysis

Background:

  • Chronic kidney disease (CKD) poses a significant health challenge in children.
  • Identifying progression risk factors is crucial for timely intervention and management.
  • Limited data exists on CKD progression in pediatric populations in the Southern Hemisphere.

Purpose of the Study:

  • To identify risk factors associated with CKD progression in Brazilian children.
  • To investigate interactions between identified risk factors.
  • To provide data for developing strategies to slow CKD evolution in pediatric patients.

Main Methods:

  • A multicenter prospective cohort study involving 209 children with CKD stages 3-4 in São Paulo.
  • Outcomes included death, initiation of kidney replacement therapy, or a >50% decrease in estimated glomerular filtration rate (eGFR).
  • Univariate and multivariable Cox regression models were used to analyze 13 risk factors and their interactions.

Main Results:

  • The composite outcome occurred in 21% of children over a median follow-up of 2.5 years.
  • Significant risk factors for CKD progression were advanced CKD stage, nephrotic proteinuria, age, systolic blood pressure Z-score, and anemia.
  • A significant interaction was found between anemia and nephrotic proteinuria, suggesting anemia may be more detrimental in patients without proteinuria.

Conclusions:

  • This study, the first CKD cohort in the Southern Hemisphere, confirms risk factors similar to those reported in developed countries.
  • Findings support the potential for therapeutic interventions to slow CKD progression in children.
  • The interaction between anemia and proteinuria requires further research to elucidate its clinical implications.
Abstract

Related Concept Videos

Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
820
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
503
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
363
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area.
267
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
758
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
441